Ligand validation:3L65

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 3L65 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3L65_FMN_A_1401	98%	27%	0.068	0.994	1.83	1.12	7	3	1	0	100%	1
4UTJ_FMN_A_1362	100%	48%	0.043	0.994	1.13	0.89	3	2	0	0	100%	1
4UTH_FMN_A_1361	100%	45%	0.043	0.989	1.11	1.02	4	3	0	0	100%	1
3L66_FMN_A_1401	100%	24%	0.052	0.993	1.79	1.31	7	7	0	0	100%	1
4UTI_FMN_A_1361	99%	16%	0.052	0.991	2.17	1.54	10	10	0	0	100%	1
3L5L_FMN_A_1401	99%	36%	0.056	0.994	1.6	0.95	6	2	1	0	100%	1
4XHF_FMN_D_301	100%	16%	0.023	0.996	2.39	1.31	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.